6 employees
NOVEL STEM CELL TECHNOLOGY TARGETING UNMET MEDICAL NEEDS
2017
$2.8M
from 2 investors over 2 rounds
APstem Therapeutics raised $2.8M on September 1, 2020
Investors: Beyond Ventures 海闊天空創投 and Oriza Ventures